Walbrook PR Appointed By Nuformix plc
01 May 2021
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to Nuformix plc (LSE:NFX), a pharmaceutical development company and drug repurposing specialist. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.